Finance

Lists
MDT:NYSE
Medtronic PLC
$ 82.35
-1.13%
(-0.94) 1D
$ 82.06
-0.35% (-0.29)
After hours
Closed: 7-р сарын 21, 16:00:06 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDT...
Open
$ 82.49
High
$ 83.29
Low
$ 81.49
Mkt. cap
105.41Т
Avg. vol.
9.30 сая
Volume
0.00
Dividend
3.50%
Quarterly dividend
$ 0.72
Ex-dividend date
2026 оны 6-р сарын 26
P/E ratio
22.09
52-wk high
$ 106.33
52-wk low
$ 73.31
EPS
$ 3.73
Beta
0.56
Shares outstanding
1.28 тэрбум
No. of employees
95 мян
Open
$ 82.49
High
$ 83.29
Low
$ 81.49
Mkt. cap
105.41Т
Avg. vol.
9.30 сая
Volume
0.00
Dividend
3.50%
Quarterly dividend
$ 0.72
Ex-dividend date
2026 оны 6-р сарын 26
P/E ratio
22.09
52-wk high
$ 106.33
52-wk low
$ 73.31
EPS
$ 3.73
Beta
0.56
Shares outstanding
1.28 тэрбум
No. of employees
95 мян
News stories
From sources across the web
Profile
Medtronic plc is an American-Irish medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue. The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter-defibrillator, and remote patient monitoring systems. They also created miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
About Medtronic PLC
CEOGeoffrey S. Martha
Employees95 мян
Founded1949
Headquarters-
Sector-
Analyst ratings
Based on 20 analysts giving stock ratings to MDT in the past 3 months
Buy
Buy
12
Hold
8
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for MDT in the last 3 months.
Highest
Current $ 82.35
$ 118.00 (+43.29%)
Average
$ 94.67 (+14.96%)
Lowest
$ 80.00 (-2.85%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew O'Brien
Piper Sandler
Hold
Reiterated
$ 85.00
+3.2%
07/14/2026
Shagun Singh Chadha
RBC Capital
Buy
Maintained
$ 118.00
+43.3%
07/13/2026
Ryan Zimmerman
BTIG
Buy
Reiterated
$ 91.00
+10.5%
07/13/2026
Travis Steed
Bank of America Securities
Buy
Maintained
$ 95.00
+15.4%
07/13/2026
Mike Kratky
Leerink Partners
Buy
Maintained
-
-
07/10/2026
Josh Jennings
TD Cowen
Buy
Reiterated
$ 100.00
+21.4%
07/10/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$ 105.00
+27.5%
07/06/2026
Joanne Wuensch
Citi
Buy
Reiterated
$ 110.00
+33.6%
07/06/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
$ 102.00
+23.9%
06/26/2026
Michael Matson
Needham
Buy
Reiterated
$ 101.00
+22.6%
06/17/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
$ 86.00
+4.4%
06/05/2026
David Roman
Goldman Sachs
Hold
Maintained
$ 83.00
+0.8%
06/04/2026
Lee Hambright
Bernstein
Buy
Maintained
$ 97.00
+17.8%
06/04/2026
Richard Newitter
Truist Financial
Hold
Reiterated
$ 86.00
+4.4%
06/04/2026
David Rescott
Robert W. Baird
Hold
Maintained
$ 85.00
+3.2%
06/04/2026
Priya Sachdeva
UBS
Hold
Reiterated
$ 85.00
+3.2%
06/04/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
06/03/2026
Rick Wise
Stifel Nicolaus
Hold
Maintained
$ 80.00
-2.9%
06/03/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$ 100.00
+21.4%
06/03/2026
Matthew Taylor
Jefferies
Hold
Reiterated
$ 95.00
+15.4%
04/24/2026
David Toung
Argus Research
Buy
Maintained
$ 115.00
+39.6%
04/06/2026
Matt Miksic
Barclays
Buy
Maintained
$ 120.00
+45.7%
04/01/2026
Nico Chen
DBS
Hold
Maintained
$ 90.00
+9.3%
03/18/2026
Unknown Analyst
CICC
Buy
Initiated
$ 121.00
+46.9%
01/30/2026
Last report
2026 оны 6-р сарын 3
Fiscal period
Q4 2026
EPS / Est. (USD)
$ 1.55 / $ 1.54
+0.56%beat
Revenue / Est. (USD)
9.81 тэрбум / 9.61 тэрбум
+2.02%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 оны 7-р сар
2025 оны 10-р сар
2026 оны 1-р сар
2026 оны 4-р сар
Revenue
8.58 тэрбум
8.96 тэрбум
9.02 тэрбум
9.81 тэрбум
Cost of goods sold
2.98 тэрбум
3.06 тэрбум
3.17 тэрбум
3.40 тэрбум
Cost of revenue
2.98 тэрбум
3.06 тэрбум
3.17 тэрбум
3.40 тэрбум
Research and development expenses
726.00 сая
754.00 сая
722.00 сая
671.00 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.78 тэрбум
2.94 тэрбум
2.93 тэрбум
3.04 тэрбум
Operating expense
3.99 тэрбум
4.08 тэрбум
4.04 тэрбум
4.25 тэрбум
Total operating expenses
6.98 тэрбум
7.14 тэрбум
7.21 тэрбум
7.64 тэрбум
Operating income
1.60 тэрбум
1.82 тэрбум
1.80 тэрбум
2.16 тэрбум
Other non operating income
68.00 сая
3.00 сая
13.00 сая
154.00 сая
EBT including unusual items
1.30 тэрбум
1.60 тэрбум
1.40 тэрбум
1.84 тэрбум
EBT excluding unusual items
1.62 тэрбум
1.68 тэрбум
1.66 тэрбум
2.16 тэрбум
Income tax expense
255.00 сая
215.00 сая
254.00 сая
575.00 сая
Effective tax rate
19.59%
13.47%
18.10%
31.34%
Other operating expenses
72.00 сая
-29.00 сая
-79.00 сая
126.00 сая
Net income
1.04 тэрбум
1.37 тэрбум
1.14 тэрбум
1.24 тэрбум
Net profit margin
12.12%
15.33%
12.68%
12.68%
Earnings per share
1.26
1.36
1.36
1.55
Interest and investment income
120.00 сая
89.00 сая
102.00 сая
73.00 сая
Interest expense
-176.00 сая
-181.00 сая
-181.00 сая
-176.00 сая
Net interest expenses
-56.00 сая
-92.00 сая
-79.00 сая
-103.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
2.31 тэрбум
2.52 тэрбум
2.52 тэрбум
2.88 тэрбум
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more